Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Barakat syndrome × Immunotherapy × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 37 Lung Neoplasms 14 Melanoma 13 Neoplasm Metastasis 12 Esophageal Neoplasms 10 Carcinoma, Hepatocellular 10 Breast Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Esophageal Squamous Cell Carcinoma 6 Rectal Neoplasms 5 Head and Neck Neoplasms 5 Colorectal Neoplasms 5 Stomach Neoplasms 4 Brain Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Recurrence 3 Neoplasms 3 Multiple Myeloma 3 Cholangiocarcinoma 3 Carcinoma, Renal Cell 3 Small Cell Lung Carcinoma 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Neoplasm, Residual 2 Nasopharyngeal Carcinoma 2 Locally Advanced Non-small Cell Lung Cancer 2

Interventions

Immunotherapy 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06518018 2024-07-24

HIBIC-NSCLC

The First People's Hospital of Neijiang

Active not recruiting

Barakat syndrome, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡